SCHEMBL1826337

SCHEMBL1826337

CCOC(=O)CC(c1cccc(OS(=O)(=O)c2ccc(C)cc2)c1)C(N)C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.37
MAPT P10636 2/20 0.37
G6PD P11413 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ALDH1A1 P00352 4/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
GPR17 Q13304 1/20 0.36
P2RX7 Q99572 2/20 0.36
DRD2 P14416 1/20 0.35
DRD1 P21728 1/20 0.35
DRD4 P21917 1/20 0.35
DRD5 P21918 1/20 0.35
DRD3 P35462 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824919 0.94 GPR17 (0.38) GAAMAPTG6PDNPSR1ALDH1A1
SCHEMBL1822400 0.94 HSD11B1 (0.37) GAAMAPTALDH1A1P2RX7MAPK1
SCHEMBL1827214 0.93 GPR17 (0.38) GAAMAPTG6PDNPSR1ALDH1A1
SCHEMBL1824907 0.91 GPR17 (0.37) GAAMAPTG6PDNPSR1ALDH1A1
SCHEMBL1826786 0.90 P2RX7 (0.45) MAPTLMNAP2RX7KMT2A
SCHEMBL1827152 0.89 ENPP1 (0.40) GAAMAPTNPSR1ALDH1A1LMNA
SCHEMBL1821110 0.88 F10 (0.34) GAAMAPTALDH1A1HPGDL3MBTL1
SCHEMBL1823114 0.87 GAA (0.39) GAAMAPTG6PDNPSR1ALDH1A1
SCHEMBL1824410 0.87 ABCB1 (0.37) MAPTALDH1A1GPR17P2RX7KMT2A
SCHEMBL1825487 0.85 LMNA (0.41) GAAMAPTG6PDNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 GAA 2170/4885MAPT 4712/4885G6PD 2532/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 GAA 98/4885MAPT 2237/4885G6PD 3528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.